Daniele Gerion
Advertisement
Daniele Gerion is a senior scientist at LamdaGen Corporation
Articles by Daniele Gerion
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
2
China Grants Ivonescimab Priority Review in Biliary Tract Cancer
3
Boehringer Ingelheim Licenses Six Preclinical ADC and T-Cell Engager Programs From SBP Group in Deal Worth Up to $7 Billion
4
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than Ezetimibe
5